💉 Tirzepatide 30 mg / 3 mL Injection Pen

🏷️ Spectrum Pharma

🧾 Product Overview

💉 Tirzepatide is a prescription injectable medication formulated as a prefilled injection pen for subcutaneous use.

It works through a dual mechanism on GLP-1 and GIP receptors, supporting metabolic balance, blood sugar control, and appetite regulation.

🧪 Active Ingredient

💉 Tirzepatide

💊 Pharmaceutical Form

💉 Prefilled Injection Pen

📍 Route of administration: Subcutaneous (SC)

📦 Strength & Presentation

• 💉 Total content: 30 mg Tirzepatide
• 💉 Volume: 3 mL per pen
• 💉 Concentration: 10 mg/mL
• 📦 Packaging: Prefilled multi-dose pen (manufacturer-specific)

🧠 Mechanism of Action

Tirzepatide supports metabolic function by:

• 💉 Increasing glucose-dependent insulin secretion
• 💉 Suppressing glucagon release
• 💉 Slowing gastric emptying
• 💉 Reducing appetite and caloric intake

Its dual GIP & GLP-1 receptor activation provides enhanced metabolic efficiency.

🎯 Indications

• 💉 Type 2 Diabetes Mellitus management
• 💉 Weight management & appetite control (under medical supervision)

📍 Dosage & Administration

• 💉 Once-weekly subcutaneous injection
• 📍 Injection sites:
  • Abdomen
  • Thigh
  • Upper arm

⚠️ The 30 mg indicated on the pen represents total content, not a single injection dose.

📈 Gradual dose titration is recommended for improved tolerability.

⚠️ Safety & Side Effects

🔹 Common Side Effects:

• 💉 Nausea
• 💉 Vomiting
• 💉 Diarrhea
• 💉 Constipation
• 💉 Decreased appetite

🔺 Serious Warnings:

• ⚠️ Potential risk of thyroid C-cell tumors
• ⚠️ Pancreatitis
• ⚠️ Gallbladder disorders
• ⚠️ Injection-site reactions

❌ Not recommended for patients with MEN 2 or medullary thyroid carcinoma (MTC).

👨‍⚕️ Use strictly under medical supervision.

❄️ Storage Conditions

• 🧊 Store refrigerated as per manufacturer instructions
• ❌ Do not freeze
• 🌑 Protect from light

📜 Regulatory Status

• 📌 Prescription-only injectable medicine
• 📌 Intended for controlled medical use

🧠 Summary

💉 Tirzepatide 30 mg / 3 mL Injection Pen – Spectrum Pharma is a high-strength injectable formulation designed for once-weekly subcutaneous administration.

It provides effective support for glycemic control and weight management through a dual incretin mechanism, when used as part of a medically supervised  treatment plan